Norovirus infectious disease

This early-stage trial is testing whether a new oral vaccine can safely protect against norovirus, the highly contagious virus that causes vomiting and diarrhea. Healthy adults aged 18 to 80 will receive a single dose of the vaccine, which targets two common norovirus strains. Re…

This early-stage trial tested an oral norovirus vaccine in 76 healthy breastfeeding mothers to see if it is safe and can trigger immune responses in both mom and her breastmilk. The vaccine is taken as a tablet and targets two common norovirus strains. Researchers hope that antib…

This large phase 3 trial tested a new norovirus vaccine in 8,000 healthy children aged 6 months to 13 years. The vaccine targets two common norovirus strains (GⅠ.1 and GⅡ.4) that cause severe vomiting and diarrhea. Researchers compared vaccinated kids to those who got a placebo t…

This study tested an experimental oral vaccine designed to protect against norovirus, a highly contagious virus that causes vomiting and diarrhea. Healthy adults aged 18 to 49 received either a single dose of the vaccine or a placebo. About a month later, all volunteers were inte…